Lead party: ThirdWay Capital (lead investor/buyer)
Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).
Target: Fluorobiotech (Pty) Ltd (private company) · Sector: Healthcare, Pharmaceuticals, Biotechnology · Countries of operation: South Africa
Transaction type: Investment · Asset class: Venture Capital · Strategy: Venture Equity · Instrument: Equity · Round: Growth Capital
Lead investor/buyer: ThirdWay Capital · Investors/buyers: ThirdWay Capital
Legal advisers: not identified in the source record.
Source: announced 12 March 2026. Original announcement: linkedin.com.


